ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, everyone, and welcome to the ImmuCell Corporation’s Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. And now I would like to turn the conference over to Joe Diaz. Please go ahead. Joe Diaz: […]
Unleashing growth: Maine s emerging Silicon Valley for animal health mainebiz.biz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mainebiz.biz Daily Mail and Mail on Sunday newspapers.
Operator: Good morning, and welcome to ImmuCell Corporation Reports First Quarter 2023 Unaudited Financial Results Conference Call. All participants will be in a listen-only mode.
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist from Dana-Farber Cancer Institute.
Three-Drug Combo Slows Progression of Advanced Kidney Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.